PGXL client ViaQuest is using pharmacogenetics to help manage pain for it’s hospice patients.
“Knowing which medication is genetically effective for that individual has the potential to directly impact one’s quality of life while providing comfort,” says Kathy Richard, ViaQuest’s Chief Clinical Officer. “
Providing the genetic information is a PGXL-developed pain panel that provides a 360-degree view of the patients’ drug sensitivities. That improves the chances that the patient’s pain will be alleviated while decreasing chances of with overmedication or adverse drug reaction.
Read a white paper on the project here.